- Home
- LODE vs INO Comparison
LODE vs INO Comparison
Compare LODE & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LODE | INO |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.1M | 136.6M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | LODE | INO |
|---|---|---|
| Price | $3.48 | $2.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $4.00 | ★ $9.00 |
| AVG Volume (30 Days) | 828.9K | ★ 1.1M |
| Earning Date | 10-30-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,778,445.00 | $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,798.62 | $21,219.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 48.99 | N/A |
| 52 Week Low | $1.67 | $1.30 |
| 52 Week High | $10.10 | $2.98 |
Technical Indicators
Market Signals| Indicator | LODE | INO |
|---|---|---|
| Relative Strength Index (RSI) | 53.34 | 70.15 |
| Support Level | $3.19 | $2.03 |
| Resistance Level | $3.70 | $2.37 |
| Average True Range (ATR) | 0.26 | 0.16 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 54.03 | 84.30 |
Price Performance
Historical ComparisonAbout LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.